L26/P-717 Cumulative live birth after unstimulated in vitro maturation versus conventional in vitro fertilization in women with polycystic ovary syndrome: a 36-month retrospective matched cohort study
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1044 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von G. Wei und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does unstimulated in vitro maturation (IVM) achieve cumulative live birth rates (CLBRs) comparable to those of conventional in vitro fertilization (IVF) in PCOS? Summary answer IVM showed lower CLBR, but frozen embryo transfers achieved similar live birth rates to IVF, with no severe ovarian hyperstimulation syndrome (OHSS) in PCOS. What is known already Polycystic ovary syndrome (PCOS) patients face a heightened risk of ovarian hyperstimulation syndrome (OHSS) during conventional gonadotropin stimulation. Strictly unstimulated in vitro maturation (IVM) is an alternative strategy that completely avoids ovarian stimulation, thereby eliminating OHSS risk and reducing treatment burden. However, the efficacy of IVM is often debated due to historically lower oocyte yields compared to stimulated IVF. Crucially, long-term outcomes, specifically cumulative live birth rates (CLBR) over an extended period, remain insufficiently defined, particularly when stratifying outcomes by baseline ovarian phenotypes such as antral follicle count. Study design, size, duration This retrospective matched cohort study was conducted at a university-affiliated fertility center. We analyzed data from women treated between January 2010 and December 2022, with follow-up through December 2023. A total of 545 women undergoing strictly unstimulated IVM were matched 1:3 by age and body mass index (BMI) to 1,635 women undergoing conventional IVF using a gonadotropin-releasing hormone antagonist protocol. Participants/materials, setting, methods Participants were women aged 20–42 years diagnosed with PCOS according to the Rotterdam criteria. The primary outcome was the 36-month CLBR per initiated oocyte retrieval cycle. Secondary outcomes included implantation rates, live birth rates after first transfer (fresh versus frozen), and OHSS incidence. Odds ratios (ORs) were calculated for the freeze-all subset. Comparisons were stratified by antral follicle count (AFC) to assess phenotype-specific outcomes. Main results and the role of chance The 36-month CLBR per initiated cycle was significantly lower in the IVM group than in IVF (22.20% vs 47.95%; P < 0.001), primarily due to lower oocyte yields. Similarly, CLBR per embryo transfer cycle was lower with IVM (31.43% vs 50.19%; P < 0.001). However, the embryo transfer strategy significantly influenced outcomes. While LBR after the first fresh transfer was lower with IVM (25.96% vs 33.20%; P = 0.029), LBR after the first frozen embryo transfer (FET) was comparable between groups (33.33% vs 36.61%; P = 0.486). Notably, the implantation rate in frozen cycles was significantly higher in the IVM group than in IVF (43.86% vs 32.62%; P = 0.007). In the subgroup of women with high ovarian reserve (AFC ≥24), LBR after the first FET showed no significant difference (OR 0.99, 95% CI 0.57–1.72). Safety was superior in the IVM group, with 0% severe OHSS compared to 0.98% in the IVF group Limitations, reasons for caution Limitations include the retrospective design, which may introduce selection bias despite matching. The 12-year study period implies evolving laboratory and clinical practices, including a shift toward freeze-all strategies, which may influence outcomes. Results may not be generalizable to centers with different IVM protocols. Wider implications of the findings These findings advocate for a ‘freeze-all’ IVM strategy to optimize reproductive outcomes in PCOS women. IVM eliminates OHSS risk while achieving comparable success rates to IVF in frozen cycles, offering a safer alternative for high-responder phenotypes without compromising per-transfer efficacy. Trial registration number Yes
Zitieren
APA
Wei, G., Linlin, W., Xiumei, Z., Rong, L., & Jie, Q. (2026). L26/P-717 Cumulative live birth after unstimulated in vitro maturation versus conventional in vitro fertilization in women with polycystic ovary syndrome: a 36-month retrospective matched cohort study. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1044
Vancouver
Wei G, Linlin W, Xiumei Z, Rong L, Jie Q. L26/P-717 Cumulative live birth after unstimulated in vitro maturation versus conventional in vitro fertilization in women with polycystic ovary syndrome: a 36-month retrospective matched cohort study. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1044
BibTeX
@article{Wei2026,
author = {Wei, G. and Linlin, W. and Xiumei, Z. and Rong, L. and Jie, Q.},
title = {L26/P-717 Cumulative live birth after unstimulated in vitro maturation versus conventional in vitro fertilization in women with polycystic ovary syndrome: a 36-month retrospective matched cohort study},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1044}
}
EUVIMED